| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
28,532 |
22,580 |
$1.03M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,028 |
1,755 |
$59K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
951 |
830 |
$42K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,414 |
1,050 |
$12K |
| 99454 |
|
324 |
276 |
$6K |
| 99457 |
|
325 |
277 |
$5K |
| 99458 |
|
324 |
276 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
3,300 |
2,782 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
150 |
127 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
351 |
270 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
224 |
158 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
141 |
112 |
$1K |
| 80305 |
|
202 |
143 |
$897.65 |
| 81003 |
|
867 |
730 |
$846.91 |
| 90674 |
|
94 |
79 |
$742.03 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
25 |
21 |
$718.34 |
| 90686 |
|
33 |
25 |
$290.32 |
| 1111F |
|
138 |
133 |
$190.83 |
| 87430 |
|
19 |
16 |
$182.40 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
14 |
14 |
$77.55 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
362 |
309 |
$48.82 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
64 |
54 |
$41.01 |
| J0698 |
Injection, cefotaxime sodium, per gm |
14 |
12 |
$36.79 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
20 |
12 |
$24.78 |